In-hospital initiation of lipid-lowering therapy in patients with atherosclerosis is recommended to reduce recurrent events and improve long-term compliance.
No takes yet. Share an insight, caveat, or question.
Supports in-hospital lipid-lowering initiation in atherosclerotic disease; leaves open need for randomized confirmation of benefits.
Gregg C. Fonarow (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: